SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-046017
Filing Date
2024-04-19
Accepted
2024-04-19 16:15:22
Documents
18
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A beam-20240419.htm   iXBRL DEF 14A 1378598
2 GRAPHIC img43955338_0.jpg GRAPHIC 5356
3 GRAPHIC img43955338_1.jpg GRAPHIC 3067
4 GRAPHIC img43955338_2.jpg GRAPHIC 5356
5 GRAPHIC img43955338_3.jpg GRAPHIC 228425
6 GRAPHIC img43955338_4.jpg GRAPHIC 218466
7 GRAPHIC img43955338_5.jpg GRAPHIC 472123
8 GRAPHIC img43955338_6.jpg GRAPHIC 245529
  Complete submission text file 0000950170-24-046017.txt   4615381

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT beam-20240419.xsd EX-101.SCH 34916
21 EXTRACTED XBRL INSTANCE DOCUMENT beam-20240419_htm.xml XML 112735
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39208 | Film No.: 24857936
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)